APA (7th ed.) Citation

TM, T., CO, A., TS, T., MDP, D., CL, B., A, A., . . . GH, N. (2025). Secukinumab in bio-experienced patients with moderate-to-severe hidradenitis suppurativa from a single center: An observational retrospective study. International journal of dermatology, 64(5), 949. https://doi.org/10.1111/ijd.17583

Chicago Style (17th ed.) Citation

TM, Tran, Akpala CO, Tran TS, Davis MDP, Baum CL, Alavi A, Wetter DA, and Nguyen GH. "Secukinumab in Bio-experienced Patients with Moderate-to-severe Hidradenitis Suppurativa from a Single Center: An Observational Retrospective Study." International Journal of Dermatology 64, no. 5 (2025): 949. https://doi.org/10.1111/ijd.17583.

MLA (9th ed.) Citation

TM, Tran, et al. "Secukinumab in Bio-experienced Patients with Moderate-to-severe Hidradenitis Suppurativa from a Single Center: An Observational Retrospective Study." International Journal of Dermatology, vol. 64, no. 5, 2025, p. 949, https://doi.org/10.1111/ijd.17583.